IPO registrations (S-1, F-1) · Registrants
IMPACT BIOMEDICAL INC.
- SEC CIK
- 1834105 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-02-12, last 2024-08-27; 2 initial registrations, 21 amendments
- Outcome
- Final prospectus filed 2024-09-17; declared effective 2023-08-04
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- NV
- Business address
- 275 WIREGRASS PKWY,, West Henrietta, NY 14586
- EIN
- 85-3926944
- Ticker
- IBO (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- IMPACT BIOMEDICAL INC. on the corporate pages
Offering terms
- Proposed price range
- $3.00–$5.00 per share (S-1/A filed 2024-08-20)
- Final price
- $3.00 per share, within the range (424B4 filed 2024-09-17)
- Shares sold
- 1,500,000
- Gross proceeds
- $4,500,000 before underwriting discounts and any over-allotment option
- Listing
- NYSE American under the symbol IBO
- Lead underwriters
- of Contents; Note Regarding Forward Looking Statements
- Syndicate
- Revere Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: IMPACT BIOMEDICAL INC Fuzzy (name and state)
- SEC filer: IMPACT BIOMEDICAL INC. EXACT (CIK (EXACT))
Filings 26
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-02-12 | S-1 | S-1 (registration) | IMPACT BIOMEDICAL INC. | 0001493152-21-003571 ↗ |
| 2021-09-29 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-21-024112 ↗ |
| 2022-06-24 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-22-017756 ↗ |
| 2022-07-11 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-22-018988 ↗ |
| 2022-08-02 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-22-021049 ↗ |
| 2022-08-24 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-22-023938 ↗ |
| 2022-12-07 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-22-034778 ↗ |
| 2023-01-09 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-000961 ↗ |
| 2023-01-31 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-003170 ↗ |
| 2023-05-15 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-017566 ↗ |
| 2023-06-02 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-019982 ↗ |
| 2023-06-21 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-021957 ↗ |
| 2023-06-30 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-023121 ↗ |
| 2023-07-24 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-025388 ↗ |
| 2023-08-01 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-026281 ↗ |
| 2023-08-04 | EFFECT | EFFECT (declared effective) | IMPACT BIOMEDICAL INC. | 9999999995-23-002278 ↗ |
| 2023-10-17 | S-1 | S-1 (registration) | IMPACT BIOMEDICAL INC. | 0001493152-23-037534 ↗ |
| 2023-11-01 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-039032 ↗ |
| 2023-11-21 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-23-042218 ↗ |
| 2024-02-28 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-24-008226 ↗ |
| 2024-06-11 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-24-023488 ↗ |
| 2024-08-09 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-24-030934 ↗ |
| 2024-08-20 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-24-033267 ↗ |
| 2024-08-27 | S-1/A | S-1/A (amendment) | IMPACT BIOMEDICAL INC. | 0001493152-24-034009 ↗ |
| 2024-09-13 | EFFECT | EFFECT (declared effective) | IMPACT BIOMEDICAL INC. | 9999999995-24-002832 ↗ |
| 2024-09-17 | 424B4 | 424B4 (final prospectus) | IMPACT BIOMEDICAL INC. | 0001493152-24-036520 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-20 | S-1/A | registration statement | $3.00–$5.00 | $3.00 | 1,500,000 | $4,500,000 | NYSE American IBO | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2024-08-27 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2024-09-17 | 424B4 | final prospectus | $3.00 | 1,500,000 | $4,500,000 | NYSE American IBO | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Brownell Elise | Director | 1 | 2024 | ||
| Chan Heng Fai Ambrose | Director; Director,TenPercentOwner; TenPercentOwner | 4 | 2024–2025 | ||
| Grady Jason | Director | 2 | 2024–2026 | ||
| Heuszel Frank D | Director,Officer | CEO and President; Chief Executive Officer | 4 | 2024 | |
| Hibbert Castel Berisford | Director | 1 | 2024 | ||
| Keene David K | Director | 1 | 2024 | ||
| Macko Todd D | Officer | Chief Financial Officer | 2 | 2024–2026 | |
| Sims Melissa Kaye | Director | 1 | 2024 | ||
| Suseck Mark | Officer | Chief Operating Officer | 1 | 2024 | |
| Zimmerman Christian Thomas | Director | 1 | 2024 | ||
| DSS, INC. | TenPercentOwner | 11 | 2024–2026 | ||
| Alset Inc. | TenPercentOwner | 2 | 2025 | ||
| Alset International Ltd | TenPercentOwner | 2 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | IMPACT BIOMEDICAL INC | NY | State business registries | name and state |
| SEC filer | IMPACT BIOMEDICAL INC. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NY first:
- TG THERAPEUTICS, INC. NY
- SIGA TECHNOLOGIES INC NY
- SEELOS THERAPEUTICS, INC. NY
- Protagenic Therapeutics, Inc.\new NY
- XTL BIOPHARMACEUTICALS LTD NY
- PENWEST PHARMACEUTICALS CO NY
- CHEMBIO DIAGNOSTICS, INC. NY
- EYETECH PHARMACEUTICALS INC NY
- INNOVATIVE DRUG DELIVERY SYSTEMS INC NY
- EON LABS INC NY
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health